A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

For advancements to be made in pathophysiology and medication development of Parkinson’s disease, reliable disease models need ... By consistently adapting to new regulatory challenges and guidelines, ...

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

Most treatments for Parkinson's disease (PD) only slow disease progression. Early intervention for the neurological disease ...

Subthalamic nucleus stimulation is an effective treatment for motor complications and dyskinesia in Parkinson's disease, but is less effective on axial signs. Alternative treatments for axial ...

A drug used for Parkinson's disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the ...

A new study shows AI can detect Parkinson’s disease with 94.4% accuracy by analyzing volatile organic compounds in earwax ...

Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...